Release Date: 04/12/09 15:56 Summary: Appendix 3B / Top 20 Securityholders Price Sensitive: No Download Document 305.43KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%